Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2944
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00829647 | A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia | ||
| NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | ||
| NCT07917832 | Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma | ||
| NCT00979316 | Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects | ||
| NCT07255404 | A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer | ||
| NCT04772079 | A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis | ||
| NCT05320094 | A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants | ||
| NCT07602946 | SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma | ||
| NCT02960854 | A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. | ||
| NCT01250366 | Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects | ||
| NCT04477629 | Belatacept in De Novo Heart Transplantation | ||
| NCT00673231 | Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin | ||
| NCT02845323 | Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder | ||
| NCT02346942 | Factors Associated With Biologic DMARD Switching | ||
| NCT03226756 | Nivolumab in Recurrent and/or Metastatic SCCHN | ||
| NCT03623854 | Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | ||
| NCT04022980 | Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma | ||
| NCT00884546 | Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma | ||
| NCT00619073 | PACT (Platelet Activity After Clopidogrel Termination) | ||
| NCT02323594 | A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir | ||
| NCT00940524 | Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia | ||
| NCT00374179 | CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma | ||
| NCT03208322 | Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults | ||
| NCT06094296 | A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) | ||
| NCT00002041 | Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients | ||
| NCT02096705 | Phase III Insulin Add-On Asia Regional Program - ST | ||
| NCT03048136 | A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer | ||
| NCT04584307 | Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant | ||
| NCT02368301 | Expanded Access Treatment Protocol CA204-143 | ||
| NCT00869401 | Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT04577729 | The IRMI-FMT Trial | ||
| NCT05543629 | A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer | ||
| NCT00001045 | Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease | ||
| NCT00028067 | A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor | ||
| NCT00494611 | A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients | ||
| NCT03508271 | Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure | ||
| NCT03084419 | APRIL (AbatacePt in Rheumatoid Arthritis-ILD) | ||
| NCT00570700 | Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer | ||
| NCT00561964 | Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria | ||
| NCT02775292 | Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 | ||
| NCT00609999 | Ph I Dasatinib + Erlotinib in Recurrent MG | ||
| NCT07293351 | A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) | ||
| NCT05469737 | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) | ||
| NCT05048212 | A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases | ||
| NCT06764771 | A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors | ||
| NCT03920267 | Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus | ||
| NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | ||
| NCT02983006 | Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma | ||
| NCT03867916 | Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients | ||
| NCT00207012 | MAD Refractory: Solid Tumor QD w/o Break |
